Free Newsletter
Computer Sciences Corp. (CSC)
Computer Sciences Corp. (CSC)
CSC's Trusted Cloud Services put the emphasis on security. The company's security offerings have been developed for many industries; cloud services span private, hybrid and public clouds.
The company is also a provider of the Windows Azure platform and a reseller of the Microsoft Business Productivity Online Suite (BPOS). Trusted Cloud Services integrate Microsoft Exchange, SharePoint, Office Communicator and LiveMeeting.
Cloud services cover infrastructure, application platform, SaaS, and business process as a service. Orchestration Services provide automated arrangement, coordination, federation, management, security and operation of computing environments, for compliance and auditing.
The key to restoring information assurance is to provide transparency into the cloud. As visibility is gained, configurations are known and verified, data exposure and use is reported, access permissions are discovered and validated, processing and data locations are exposed, compliance evidence can be gathered and analyzed, and processing risks and readiness become known. When this level of visibility and transparency is built into the cloud solution, then security, compliance and value are captured as well.
- Security: Programs for compliance management, IT infrastructure and application protection and disaster recovery.
- Agility: Just in time, on-demand availability. Cloud Orchestration Services for integration that provides service level management, remote monitoring, reporting, auditing and data transparency.
- Cost elements: Standardized pricing on a pay-per-use basis. Our standard Service Level Agreement can also be customized to meet enterprise demands. This does require additional costs and becomes a CSC Trusted Cloud Managed Service.
- Biopharma suitability: Private, public and hybrid clouds; Cloud Orchestration Services.
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




